Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Belzutifan
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Belzutifan Welireg
®
(40 mg film-coated tablets)
Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Belzutifan
Belzutifan [Specialist Drug]
Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Links found
NICE TA1011: Belzutifan for treating tumours associated with von Hippel-Lindau disease
Welireg ® (belzutifan) Patient alert cards to minimise the risk of hypoxia related adverse reactions